Media Hub

Jul 2017

Kidney cancer drug given approval for NHS use for England

The drug, cabozantinib, can potentially turn off tumours and prolong the lives of patients with advanced kidney cancer. Treatment options for kidney cancer are currently limited and according to the charity Kidney Research UK, the new drug would offer patients “more hope and more time with their loved ones”. The drug works by targeting molecules…

Read More